CN100502839C - 用于天然结合型雌激素混合物压片的预制剂 - Google Patents
用于天然结合型雌激素混合物压片的预制剂 Download PDFInfo
- Publication number
- CN100502839C CN100502839C CNB2006101684418A CN200610168441A CN100502839C CN 100502839 C CN100502839 C CN 100502839C CN B2006101684418 A CNB2006101684418 A CN B2006101684418A CN 200610168441 A CN200610168441 A CN 200610168441A CN 100502839 C CN100502839 C CN 100502839C
- Authority
- CN
- China
- Prior art keywords
- preformulation
- weight
- pharmacopedics
- mixture
- hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (39)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01129840 | 2001-12-14 | ||
EP01129840.3 | 2001-12-14 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028262077A Division CN1298313C (zh) | 2001-12-14 | 2002-12-12 | 用于天然结合型雌激素混合物压片的预制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1977862A CN1977862A (zh) | 2007-06-13 |
CN100502839C true CN100502839C (zh) | 2009-06-24 |
Family
ID=8179550
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101684418A Expired - Fee Related CN100502839C (zh) | 2001-12-14 | 2002-12-12 | 用于天然结合型雌激素混合物压片的预制剂 |
CNB028262077A Expired - Fee Related CN1298313C (zh) | 2001-12-14 | 2002-12-12 | 用于天然结合型雌激素混合物压片的预制剂 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028262077A Expired - Fee Related CN1298313C (zh) | 2001-12-14 | 2002-12-12 | 用于天然结合型雌激素混合物压片的预制剂 |
Country Status (14)
Country | Link |
---|---|
US (2) | US8273728B2 (zh) |
EP (1) | EP1458363B1 (zh) |
JP (1) | JP4695838B2 (zh) |
CN (2) | CN100502839C (zh) |
AR (1) | AR037642A1 (zh) |
AU (1) | AU2002358682B2 (zh) |
BR (1) | BR0214954A (zh) |
CA (1) | CA2470209A1 (zh) |
ES (1) | ES2403218T3 (zh) |
HK (2) | HK1075007A1 (zh) |
MX (1) | MXPA04005767A (zh) |
PL (1) | PL205544B1 (zh) |
TW (1) | TWI332400B (zh) |
WO (1) | WO2003051337A1 (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9586335B2 (en) * | 2010-01-27 | 2017-03-07 | Sd3, Llc | Blade guard with dust collection |
TWI332400B (en) * | 2001-12-14 | 2010-11-01 | Solvay Pharm Gmbh | Preformulation for the tableting of natural mixtures of conjugated estrogens |
US8349819B2 (en) | 2002-10-09 | 2013-01-08 | Dr. Reddy's Laboratories New York, Inc. | Steroid extraction process from urine sources |
US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US20090232897A1 (en) * | 2008-03-14 | 2009-09-17 | Bijayananda Sahoo | Pharmaceutical compositions comprising conjugated estrogens |
WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
WO2011008674A1 (en) * | 2009-07-16 | 2011-01-20 | Mallinckrodt Baker, Inc. | Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP2787987B1 (de) * | 2011-12-08 | 2016-06-01 | Hexal AG | Neue pharmazeutische statin-zusammensetzung |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
CA3169717A1 (en) * | 2020-02-11 | 2021-08-19 | Sheh Fung Screws Co., Ltd. | Fastener having improved wobble control, fastening system including the same, and method of forming the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1036328A (zh) * | 1987-12-22 | 1989-10-18 | 阿克佐公司 | 治疗更年期疾病和骨质疏松症的药物剂量单位 |
CN1197387A (zh) * | 1995-07-26 | 1998-10-28 | 杜拉梅德药品有限公司 | 共轭雌激素药物组合物及其应用方法 |
CN1298313C (zh) * | 2001-12-14 | 2007-02-07 | 索尔瓦药物有限公司 | 用于天然结合型雌激素混合物压片的预制剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3487152A (en) * | 1967-02-07 | 1969-12-30 | Hoffmann La Roche | Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances |
US4154820A (en) * | 1976-02-23 | 1979-05-15 | Akzona Incorporated | Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers |
DE3535536A1 (de) * | 1985-10-04 | 1987-04-09 | Lentia Gmbh | Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut |
PT927040E (pt) | 1996-08-30 | 2004-08-31 | Solvay Pharm Gmbh | Processo para a obtencao de estrogenios a partir da urina de egua |
ES2219694T3 (es) | 1996-08-30 | 2004-12-01 | Solvay Pharmaceuticals Gmbh | Procedimiento de obtencion de estrogenos a partir de orina de yegua. |
US6200289B1 (en) | 1998-04-10 | 2001-03-13 | Milestone Scientific, Inc. | Pressure/force computer controlled drug delivery system and the like |
JP2000156938A (ja) | 1998-11-19 | 2000-06-06 | Hokuto Denko Kk | 電池の充放電試験装置 |
-
2002
- 2002-11-29 TW TW091134752A patent/TWI332400B/zh not_active IP Right Cessation
- 2002-12-04 AR ARP020104698A patent/AR037642A1/es unknown
- 2002-12-12 CN CNB2006101684418A patent/CN100502839C/zh not_active Expired - Fee Related
- 2002-12-12 ES ES02792980T patent/ES2403218T3/es not_active Expired - Lifetime
- 2002-12-12 CN CNB028262077A patent/CN1298313C/zh not_active Expired - Fee Related
- 2002-12-12 BR BR0214954-0A patent/BR0214954A/pt not_active IP Right Cessation
- 2002-12-12 MX MXPA04005767A patent/MXPA04005767A/es active IP Right Grant
- 2002-12-12 EP EP02792980A patent/EP1458363B1/de not_active Expired - Lifetime
- 2002-12-12 CA CA002470209A patent/CA2470209A1/en not_active Abandoned
- 2002-12-12 WO PCT/EP2002/014104 patent/WO2003051337A1/de active Application Filing
- 2002-12-12 PL PL368730A patent/PL205544B1/pl unknown
- 2002-12-12 JP JP2003552270A patent/JP4695838B2/ja not_active Expired - Fee Related
- 2002-12-12 AU AU2002358682A patent/AU2002358682B2/en not_active Ceased
-
2004
- 2004-06-14 US US10/866,095 patent/US8273728B2/en not_active Expired - Fee Related
-
2005
- 2005-08-22 HK HK05107341A patent/HK1075007A1/xx not_active IP Right Cessation
-
2007
- 2007-08-28 HK HK07109383.9A patent/HK1104220A1/xx not_active IP Right Cessation
-
2012
- 2012-05-30 US US13/483,530 patent/US8329679B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1036328A (zh) * | 1987-12-22 | 1989-10-18 | 阿克佐公司 | 治疗更年期疾病和骨质疏松症的药物剂量单位 |
CN1197387A (zh) * | 1995-07-26 | 1998-10-28 | 杜拉梅德药品有限公司 | 共轭雌激素药物组合物及其应用方法 |
CN1298313C (zh) * | 2001-12-14 | 2007-02-07 | 索尔瓦药物有限公司 | 用于天然结合型雌激素混合物压片的预制剂 |
Also Published As
Publication number | Publication date |
---|---|
AU2002358682B2 (en) | 2009-03-26 |
TW200408400A (en) | 2004-06-01 |
JP2005516923A (ja) | 2005-06-09 |
WO2003051337A1 (de) | 2003-06-26 |
US8273728B2 (en) | 2012-09-25 |
PL368730A1 (en) | 2005-04-04 |
EP1458363B1 (de) | 2013-01-16 |
US20050009800A1 (en) | 2005-01-13 |
AR037642A1 (es) | 2004-11-17 |
JP4695838B2 (ja) | 2011-06-08 |
HK1075007A1 (en) | 2005-12-02 |
ES2403218T3 (es) | 2013-05-16 |
CA2470209A1 (en) | 2003-06-26 |
CN1298313C (zh) | 2007-02-07 |
BR0214954A (pt) | 2004-12-14 |
TWI332400B (en) | 2010-11-01 |
CN1977862A (zh) | 2007-06-13 |
PL205544B1 (pl) | 2010-04-30 |
MXPA04005767A (es) | 2004-09-10 |
AU2002358682A1 (en) | 2003-06-30 |
CN1607944A (zh) | 2005-04-20 |
HK1104220A1 (en) | 2008-01-11 |
EP1458363A1 (de) | 2004-09-22 |
US8329679B2 (en) | 2012-12-11 |
US20120237666A1 (en) | 2012-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100502839C (zh) | 用于天然结合型雌激素混合物压片的预制剂 | |
CA1338553C (en) | Pharmaceutical granulate containing cellulose product | |
EP2347756B1 (en) | Controlled agglomeration | |
CA1308024C (en) | Vitamin-containing granules and production thereof | |
Nastruzzi et al. | Influence of formulation and process parameters on pellet production by powder layering technique | |
CN100542538C (zh) | 可控制结合型雌激素天然混合物的释放的基质-膜衣片剂 | |
SK682000A3 (en) | Process for producing pellets with a pharmaceutical agent content of up to 90 % w/w | |
RU2207133C2 (ru) | Стабилизированные композиции тиболона | |
US20040013735A1 (en) | Method for granulation of active substances by low pressure extrusion to obtain directly compressible granules | |
Kukkar et al. | Mixing and formulation of low dose drugs: underlying problems and solutions | |
CA2275626C (en) | Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations | |
MXPA06015027A (es) | Granulos de alto contenido de ibuprofeno y su preparacion y su uso en formas de dosificacion farmaceutica. | |
CN105055350A (zh) | 一种含有质子泵抑制剂的片剂的制备方法 | |
WO2004110448A1 (ja) | 塩酸ベニジピン含有医薬組成物 | |
CN110123775A (zh) | 一种吲达帕胺胶囊的制备方法 | |
CN1049114C (zh) | 一种制备缓释药物制剂的方法 | |
CZ2016573A3 (cs) | Pevná formulace abirateronu acetátu vyráběná technologií fluidní granulace | |
CN104546774B (zh) | 一种格列美脲片 | |
CN111759815A (zh) | 一种盐酸二甲双胍控释片芯及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1104220 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1104220 Country of ref document: HK |
|
C56 | Change in the name or address of the patentee |
Owner name: ABBOTT PRODUCTS, INC. Free format text: FORMER NAME: SOLVAY PHARMACEUTICALS GMBH |
|
CP01 | Change in the name or title of a patent holder |
Address after: Hannover Patentee after: Solvay Pharm GmbH Address before: Hannover Patentee before: Solvay Pharmaceuticals GmbH |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090624 Termination date: 20141212 |
|
EXPY | Termination of patent right or utility model |